Student Research Symposium Program Portal: Submission #58

Abstract Neuromuscular blockade (NMB) reversal is vital for anesthesia care to prevent residual blockade, which can lead to respiratory complications and delayed recovery. This quality improvement project evaluated sugammadex, a selective NMB reversal agent, compared to the traditional neostigmine-glycopyrrolate, focusing on postoperative care unit (PACU) times in adult patients undergoing general anesthesia with rocuronium or vecuronium. Evidence from clinical guidelines and studies supported sugammadex's advantages in efficiency, safety, and cost-effectiveness. Implemented at a facility in Dothan, Alabama, the project addressed financial concerns through education, aiming to increase sugammadex utilization. Usage increased modestly by 1.38% (from 434 to 440 cases), reflecting improved provider confidence and highlighting the value of overcoming barriers to enhance patient safety and operating room efficiency.